WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006081371) COMBINATION THERAPY WITH TRITERPENOID COMPOUNDS AND PROTEASOME INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/081371    International Application No.:    PCT/US2006/002821
Publication Date: 03.08.2006 International Filing Date: 26.01.2006
IPC:
A61K 45/06 (2006.01)
Applicants: RESEARCH DEVELOPMENT FOUNDATION [US/US]; 402 North Dvision Street, Carson City, Nevada 89703 (US) (For All Designated States Except US).
GUTTERMAN, Jordan [US/US]; (US) (For US Only).
GAIKWAD, Amos [US/US]; (US) (For US Only).
POBLENZ, Ann; (For US Only).
HARIDAS, Valsala [US/US]; (US) (For US Only).
ZHANG, Chunlei; (For US Only).
DUVIC, Madeleine; (For US Only)
Inventors: GUTTERMAN, Jordan; (US).
GAIKWAD, Amos; (US).
POBLENZ, Ann; .
HARIDAS, Valsala; (US).
ZHANG, Chunlei; .
DUVIC, Madeleine;
Agent: HANSON, Robert, E.; FULBRIGHT & JAWORSKI L.L.P., 600 Congress Avenue, Suite 2400, Austin, Texas 78701 (US)
Priority Data:
60/647,513 27.01.2005 US
Title (EN) COMBINATION THERAPY WITH TRITERPENOID COMPOUNDS AND PROTEASOME INHIBITORS
(FR) THERAPIE DE COMBINAISON AVEC DES COMPOSES TRITERPENOIDES ET DES INHIBITEURS DE PROTEASOME
Abstract: front page image
(EN)The present invention provides therapeutic compositions comprising a natural triterpenoid and a proteasome inhibitor. These compositions will be particularly useful in the treatment of malignancies and inflammation. The present invention also provides methods of treating a subject having a malignancy or an inflammatory disorder comprising administering to the subject a natural triterpenoid and a proteasome inhibitor.
(FR)La présente invention concerne des compositions thérapeutiques comprenant un triterpénoïde naturel et un inhibiteur de protéasome. Ses compositions conviendront particulièrement pour le traitement de tumeurs malignes et d'inflammation. Cette invention concerne aussi des techniques de traitement d'un sujet atteint d'une tumeur mènent ou d'un trouble inflammatoire qui consistent à administrer à ce sujet un triterpenoïde naturel et un inhibiteur de protéasome.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)